---
figid: PMC5043614__fonc-06-00205-g002
figtitle: Links between altered glucose and phosphatidylcholine metabolism in breast
  cancer
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC5043614
filename: fonc-06-00205-g002.jpg
figlink: /pmc/articles/PMC5043614/figure/F2/
number: F2
caption: 'Links between altered glucose and phosphatidylcholine metabolism in breast
  cancer. Glucose metabolism occurs in cancer cells. Glycolysis is a series of metabolic
  processes, in which 1 mol of glucose is catabolized to 2 mol of pyruvate. As indicated,
  several intermediates can fuel the pentose phosphate pathway (PPP) or lead to lipid
  synthesis. In cancer cells, pyruvate is further converted into lactate. Pyruvate
  can be imported in the mitochondrial matrix to feed the tricarboxylic acid (TCA)
  cycle. This step is controlled by pyruvate dehydrogenase kinase (PDK), which can
  inactivate pyruvate dehydrogenase (PDH). Transporters: Glut, glucose transporter;
  MCT, monocarboxylate transporter. Metabolites: Ala, alanine; α-KG, α-ketoglutarate;
  DAG, diacylglycerol; G6P, glucose-6-phosphate; F6P, fructose-6-phosphate; F1,6BP,
  fructose-1,6-bisphosphate; DHAP, dihydroxyacetone phosphate; Gro3P, sn-glycerol-3-phosphate;
  GA3P, glyceraldehyde-3-phosphate; G3P, 3-phosphoglycerate; PA, phosphatidate; PEP,
  phosphoenolpyruvate; TAG, triacylglycerol. Enzymes: ACC, acetyl-CoA carboxylase;
  FAS, fatty acid synthase; HK, hexokinase; LDH, lactate dehydrogenase; PDK, pyruvate
  dehydrogenase kinase; PDH, pyruvate dehydrogenase phosphatidylcholine (PtdCho) cycle.
  Transporters: CHT1, choline high-affinity transporter-1; CTL, choline transporter-like
  protein; OCT2, organic cation transporter-2. Metabolites: CDP-Cho, cytidine diphosphate
  choline; Cho, free choline; DAG, diacylglycerol; FFA, free fatty acid; Gro3P, sn-glycerol-3-phosphate;
  GPCho, glycerophosphocholine; LPtdCho, lysophosphatidylcholine; PA, phosphatidate;
  PCho, phosphocholine. Enzymes: Kennedy pathway: ChoK, choline kinase (EC 2.7.1.32);
  CT, cytidylyltransferase (EC 2.7.7.15); PCT, phosphocholine transferase (EC 2.7.8.2).
  Headgroup hydrolysis pathways: PLC, phospholipase C (EC 3.1.4.3); PLD, phospholipase
  D (EC 3.1.4.4). Deacylation pathway: PLA1, phospholipase A1 (EC 3.1.1.32); PLA2,
  phospholipase A2 (EC 3.1.1.4); LPL, lysophospholipase (EC 3.1.1.5); PD, glycerophosphocholine
  phosphodiesterase (EC 3.1.4.2). Red arrows indicate direction of change in enzyme
  activity enzymes and metabolite content.'
papertitle: Key Players in Choline Metabolic Reprograming in Triple-Negative Breast
  Cancer.
reftext: Egidio Iorio, et al. Front Oncol. 2016;6:205.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9258565
figid_alias: PMC5043614__F2
figtype: Figure
redirect_from: /figures/PMC5043614__F2
ndex: baf5f6a0-df0a-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5043614__fonc-06-00205-g002.html
  '@type': Dataset
  description: 'Links between altered glucose and phosphatidylcholine metabolism in
    breast cancer. Glucose metabolism occurs in cancer cells. Glycolysis is a series
    of metabolic processes, in which 1 mol of glucose is catabolized to 2 mol of pyruvate.
    As indicated, several intermediates can fuel the pentose phosphate pathway (PPP)
    or lead to lipid synthesis. In cancer cells, pyruvate is further converted into
    lactate. Pyruvate can be imported in the mitochondrial matrix to feed the tricarboxylic
    acid (TCA) cycle. This step is controlled by pyruvate dehydrogenase kinase (PDK),
    which can inactivate pyruvate dehydrogenase (PDH). Transporters: Glut, glucose
    transporter; MCT, monocarboxylate transporter. Metabolites: Ala, alanine; α-KG,
    α-ketoglutarate; DAG, diacylglycerol; G6P, glucose-6-phosphate; F6P, fructose-6-phosphate;
    F1,6BP, fructose-1,6-bisphosphate; DHAP, dihydroxyacetone phosphate; Gro3P, sn-glycerol-3-phosphate;
    GA3P, glyceraldehyde-3-phosphate; G3P, 3-phosphoglycerate; PA, phosphatidate;
    PEP, phosphoenolpyruvate; TAG, triacylglycerol. Enzymes: ACC, acetyl-CoA carboxylase;
    FAS, fatty acid synthase; HK, hexokinase; LDH, lactate dehydrogenase; PDK, pyruvate
    dehydrogenase kinase; PDH, pyruvate dehydrogenase phosphatidylcholine (PtdCho)
    cycle. Transporters: CHT1, choline high-affinity transporter-1; CTL, choline transporter-like
    protein; OCT2, organic cation transporter-2. Metabolites: CDP-Cho, cytidine diphosphate
    choline; Cho, free choline; DAG, diacylglycerol; FFA, free fatty acid; Gro3P,
    sn-glycerol-3-phosphate; GPCho, glycerophosphocholine; LPtdCho, lysophosphatidylcholine;
    PA, phosphatidate; PCho, phosphocholine. Enzymes: Kennedy pathway: ChoK, choline
    kinase (EC 2.7.1.32); CT, cytidylyltransferase (EC 2.7.7.15); PCT, phosphocholine
    transferase (EC 2.7.8.2). Headgroup hydrolysis pathways: PLC, phospholipase C
    (EC 3.1.4.3); PLD, phospholipase D (EC 3.1.4.4). Deacylation pathway: PLA1, phospholipase
    A1 (EC 3.1.1.32); PLA2, phospholipase A2 (EC 3.1.1.4); LPL, lysophospholipase
    (EC 3.1.1.5); PD, glycerophosphocholine phosphodiesterase (EC 3.1.4.2). Red arrows
    indicate direction of change in enzyme activity enzymes and metabolite content.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ntrk1
  - Egfr
  - Mtor
  - Akt1
  - Pik3r1
  - Ephb2
  - Mapk1
  - Mdk
  - ras
  - Hras
  - Kras
  - Rem1
  - Trp53
  - Myc
  - Nol3
  - Col11a1
  - Plxna2
  - Hk
  - G6pdx
  - Rab38
  - Chka
  - Klra4
  - Tag
  - Wdtc1
  - Mdga2
  - Slc25a1
  - Prep
  - Ptpn22
  - Fndc5
  - Lct
  - Fas
  - Fasn
  - mct1
  - Slc16a1
  - Mcts1
  - Acc
  - Matn1
  - Abcg5
  - Hspg2
  - Lpl
  - Gnat2
  - TKTL1
  - EGFR
  - MTOR
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - EPHB2
  - MAPK1
  - MAPK3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - KRAS
  - HRAS
  - NRAS
  - TP53
  - MYC
  - PLXNA2
  - G6PD
  - UBL4A
  - SLC5A7
  - ATP8A2
  - TMED7
  - LINC01194
  - WDTC1
  - SLC25A1
  - PAEP
  - PREP
  - PTPN22
  - LCT
  - LDHA
  - LDHB
  - LDHC
  - FAS
  - FASN
  - CMA1
  - SLC16A1
  - MCAT
  - MCTS1
  - ACACA
  - BMS1
  - ACACB
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - CALCA
  - UROD
  - MATN1
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - GPLD1
  - PLD1
  - PLD2
  - PLD3
  - PLD4
  - PLD5
  - PLD6
  - LPL
  - LCP1
  - lov
  - Tor
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Erk7
  - rl
  - Dsor1
  - Mtk
  - Ras64B
  - Ras85D
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - VhaAC39-1
  - ctl
  - cutlet
  - Zw
  - ChT
  - Cht11
  - Cht6
  - mbl
  - Cht8
  - Cht9
  - Cht2
  - Cht7
  - Cht5
  - Cht4
  - Cht12
  - chaetae
  - Cht10
  - G6P
  - amon
  - ATPsynbeta
  - Atpalpha
  - Pa
  - adp
  - ctp
  - Pep
  - bgcn
  - ct
  - Lac
  - lacquered
  - Ldh
  - Fas2
  - FASN1
  - Fas3
  - fand
  - tei
  - rg
  - FASN2
  - FASN3
  - Mct1
  - ACC
  - tacc
  - acclinal-wing
  - Pdk
  - Pdk1
  - cmp
  - norpA
  - sl
  - Plc21C
  - Pld
  - CycE
  - cyc
  - Pla
  - Acyl-CoA
  - Ala
  - Cholesterol
  - CMP
  - Glucose
  - Glutamine
  - Pyruvate
  - Ribose
  - Sphingolipids
  - Glutamate
  - Glu
  - Cancer
  - Lung cancer
---
